Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 17, 2006New study seeks to define potential of Precision™ system to treat large population of U.S. migraine sufferers who don't respond adequately to current therapies
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient in the PRISM (Precision® Implantable Stimulator for Migraine)...
-
Apr 11, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has received antitrust clearance from the European Commission regarding its...
-
Apr 7, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2006...
-
Apr 5, 2006Agreement subject to approval by FTC Commissioners
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement containing consent orders with the staff of the...
-
Apr 3, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the newest addition to its broad portfolio of vascular access products with the launch of...
-
Mar 31, 2006
Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the shareholders of each...
-
Mar 30, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its ZIPwire™ Hydrophilic Guide Wire, which has received clearance...
-
Mar 29, 2006Diabetics and other complex patients see strong results with TAXUS stents
Boston Scientific Corporation (NYSE: BSX) welcomed recent results from studies presented at the annual American College of Cardiology Scientific...
-
Mar 27, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court judge in Delaware has denied the Company's motion to overturn...
-
Mar 23, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has made certain commitments to the Directorate-General for Competition of the...
-
Mar 20, 2006
Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that Institutional Shareholder...
-
Mar 15, 2006
Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V ISR...
-
Mar 14, 2006Six-month results are consistent with ARRIVE I data
Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from its ARRIVE II registry, confirming the...
-
Mar 12, 2006Complex insulin-treated diabetic population shows numerical trend toward improved MACE outcomes with TAXUS versus Cypher
Boston Scientific Corporation (NYSE: BSX) today welcomed results from the independent, multi-center STENT registry, the largest...
-
Mar 12, 2006TAXUS trials continue to deliver positive outcomes in complex cases
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS V ISR (in-stent restenosis) clinical...
-
Mar 10, 2006Team will lead CRM Group following acquisition of Guidant
Boston Scientific Corporation (NYSE: BSX) today announced that it plans to name a leadership team for its new Cardiac Rhythm Management (CRM)...
-
Mar 8, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of...
-
Mar 7, 2006Results highlight efficacy of TAXUS in most complex lesions and highest risk patients
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the annual American College of Cardiology...
-
Mar 3, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 9th Annual Lehman Brothers 2006 Global Healthcare Conference, which is...
-
Mar 2, 2006Shareholders of Both Companies to Vote on March 31, 2006
Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Securities and Exchange...
-
Mar 1, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 26th Annual Health Care Conference, which is being held...
-
Feb 15, 2006
(February 15, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS